Literature DB >> 25772484

Decrease of serum adenine nucleotide hydrolysis in an irritant contact dermatitis mice model: potential P2X7R involvement.

R F Zanin1, G L da Silva, T Erig, N D M Sperotto, C E Leite, R Coutinho-Silva, A M O Batastini, Fernanda Bueno Morrone.   

Abstract

Extracellular adenosine 5'-triphosphate (ATP) has significant effects on a variety of pathological conditions and it is the main physiological agonist of P2X7 purinergic receptor (P2X7R). It is known that ATP acting via purinergic receptors plays a relevant role on skin inflammation, and P2X7R is required to neutrophil recruitment in a mice model of irritant contact dermatitis (ICD).The present study investigated the effects of chemical irritant croton oil (CrO) upon ATP, ADP, and AMP hydrolysis in mice blood serum, and the potential involvement of P2X7R. The topical application CrO induced a decrease on soluble ATP/ADPase activities (~50 %), and the treatment with the selective P2X7R antagonist, A438079, reversed these effects to control level. Furthermore, we showed that CrO decreased cellular viability (52.6 % ± 3.9) in relation to the control and caused necrosis in keratinocytes (PI positive cells). The necrosis induced by CrO was prevented by the pre-treatment with the selective P2X7R antagonist A438079. The results presented herein suggest that CrO exerts an inhibitory effect on the activity of ATPDase in mouse serum, reinforcing the idea that ICD has a pathogenic mechanism dependent of CD39. Furthermore, it is tempting to suggest that P2X7R may act as a controller of the extracellular levels of ATP.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25772484     DOI: 10.1007/s11010-015-2381-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Intravascular danger signals guide neutrophils to sites of sterile inflammation.

Authors:  Braedon McDonald; Keir Pittman; Gustavo B Menezes; Simon A Hirota; Ingrid Slaba; Christopher C M Waterhouse; Paul L Beck; Daniel A Muruve; Paul Kubes
Journal:  Science       Date:  2010-10-15       Impact factor: 47.728

Review 2.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

3.  AMP is an adenosine A1 receptor agonist.

Authors:  Joseph E Rittiner; Ilia Korboukh; Emily A Hull-Ryde; Jian Jin; William P Janzen; Stephen V Frye; Mark J Zylka
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

4.  Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells.

Authors:  P Heine; N Braun; A Heilbronn; H Zimmermann
Journal:  Eur J Biochem       Date:  1999-05

Review 5.  Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.

Authors:  Silvia Deaglio; Simon C Robson
Journal:  Adv Pharmacol       Date:  2011

6.  CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.

Authors:  Norikatsu Mizumoto; Tadashi Kumamoto; Simon C Robson; Jean Sévigny; Hiroyuki Matsue; Keiichi Enjyoji; Akira Takashima
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

Review 7.  Extracellular nucleotides as negative modulators of immunity.

Authors:  Francesco Di Virgilio; Jean-Marie Boeynaems; Simon C Robson
Journal:  Curr Opin Pharmacol       Date:  2009-07-21       Impact factor: 5.547

Review 8.  The P2X7 receptor: a key player in IL-1 processing and release.

Authors:  Davide Ferrari; Cinzia Pizzirani; Elena Adinolfi; Roberto M Lemoli; Antonio Curti; Marco Idzko; Elisabeth Panther; Francesco Di Virgilio
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  Ethical considerations in relation to pain in animal experimentation.

Authors:  M Zimmermann
Journal:  Acta Physiol Scand Suppl       Date:  1986

10.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.

Authors:  Simon C Robson; Jean Sévigny; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

View more
  5 in total

1.  AMP hydrolysis reduction in blood plasma of breast cancer elderly patients after different treatments.

Authors:  Fernanda Valente Gheler; Angélica Regina Cappellari; Daiana Renck; Julia Brandt de Souza; Renan Oliveira de Melo; Barbara Zanesco Moehlecke; Carolina Aiko Moriguchi; Paula Engroff; Ana Paula Franco Lambert; Liliana Rockenbach; Fernanda Bueno Morrone
Journal:  Mol Cell Biochem       Date:  2021-06-05       Impact factor: 3.396

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 3.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

4.  Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury.

Authors:  Francisco M Nadal-Nicolás; Caridad Galindo-Romero; Francisco J Valiente-Soriano; María Barberà-Cremades; Carlos deTorre-Minguela; Manuel Salinas-Navarro; Pablo Pelegrín; Marta Agudo-Barriuso
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

5.  Inflammasome Activation Induced by a Snake Venom Lys49-Phospholipase A2 Homologue.

Authors:  Charles Nunes Boeno; Mauro Valentino Paloschi; Jéssica Amaral Lopes; Weverson Luciano Pires; Sulamita da Silva Setúbal; Jaína Rodrigues Evangelista; Andreimar Martins Soares; Juliana Pavan Zuliani
Journal:  Toxins (Basel)       Date:  2019-12-31       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.